Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of Kewaunee Scientific Corporation (NASDAQ:KEQU) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $43.15 and traded as low as $40.61. Kewaunee Scientific shares last traded at $40.61, with a volume of 4,662 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold”.

Kewaunee Scientific Stock Performance

The stock has a fifty day simple moving average of $39.03 and a two-hundred day simple moving average of $43.15. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48. The stock has a market capitalization of $116.55 million, a price-to-earnings ratio of 10.31 and a beta of 0.55.

Kewaunee Scientific (NASDAQ:KEQU) last announced its earnings results on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. The company had revenue of $70.10 million for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.During the same quarter in the previous year, the company earned $1.01 EPS.

Insider Activity at Kewaunee Scientific

In other news, CEO Thomas David Hull III sold 2,177 shares of Kewaunee Scientific stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $37.50, for a total value of $81,637.50. Following the completion of the sale, the chief executive officer owned 33,000 shares in the company, valued at $1,237,500. The trade was a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders have sold 4,719 shares of company stock worth $179,028. Company insiders own 13.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Minerva Advisors LLC increased its stake in Kewaunee Scientific by 51.8% in the fourth quarter. Minerva Advisors LLC now owns 121,863 shares of the technology company’s stock valued at $4,559,000 after purchasing an additional 41,589 shares in the last quarter. Royce & Associates LP bought a new position in shares of Kewaunee Scientific during the 3rd quarter worth about $1,663,000. Punch & Associates Investment Management Inc. grew its stake in shares of Kewaunee Scientific by 61.9% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock valued at $2,989,000 after buying an additional 26,785 shares during the period. Northeast Investment Management bought a new stake in Kewaunee Scientific in the 4th quarter valued at about $748,000. Finally, Susquehanna International Group LLP acquired a new position in Kewaunee Scientific during the 3rd quarter worth approximately $713,000. 32.69% of the stock is owned by institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.